Cog­nate dou­bles man­u­fac­tur­ing ca­pac­i­ties in Mem­phis, Eu­rope, as de­mand for cell and gene ther­a­pies sky­rock­ets

The mar­ket­place for gene and cell man­u­fac­tur­ing ther­a­peu­tics con­tin­ues to be scorch­ing.

Cog­nate Bio­Sciences, a lead­ing CD­MO spe­cial­iz­ing in gene and cell ther­a­py tech­nolo­gies, …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER